These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 36414794)
1. Effects of Infantile Hypophosphatasia on Human Dental Tissue. Wölfel EM; von Kroge S; Matthies L; Koehne T; Petz K; Beikler T; Schmid-Herrmann CU; Kahl-Nieke B; Tsiakas K; Santer R; Muschol NM; Herrmann J; Busse B; Amling M; Rolvien T; Jandl NM; Barvencik F Calcif Tissue Int; 2023 Mar; 112(3):308-319. PubMed ID: 36414794 [TBL] [Abstract][Full Text] [Related]
2. Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia. Foster BL; Sheen CR; Hatch NE; Liu J; Cory E; Narisawa S; Kiffer-Moreira T; Sah RL; Whyte MP; Somerman MJ; Millán JL J Dent Res; 2015 May; 94(5):706-14. PubMed ID: 25716980 [TBL] [Abstract][Full Text] [Related]
3. Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice. Bowden SA; Foster BL Adv Exp Med Biol; 2019; 1148():279-322. PubMed ID: 31482504 [TBL] [Abstract][Full Text] [Related]
4. Dental defects in the primary dentition associated with hypophosphatasia from biallelic ALPL mutations. Kramer K; Chavez MB; Tran AT; Farah F; Tan MH; Kolli TN; Dos Santos EJL; Wimer HF; Millán JL; Suva LJ; Gaddy D; Foster BL Bone; 2021 Feb; 143():115732. PubMed ID: 33160095 [TBL] [Abstract][Full Text] [Related]
5. Hypophosphatasia: A Unique Disorder of Bone Mineralization. Villa-Suárez JM; García-Fontana C; Andújar-Vera F; González-Salvatierra S; de Haro-Muñoz T; Contreras-Bolívar V; García-Fontana B; Muñoz-Torres M Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919113 [TBL] [Abstract][Full Text] [Related]
6. Hypophosphatasia: From Diagnosis to Treatment. Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264 [TBL] [Abstract][Full Text] [Related]
7. Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia. Rolvien T; Schmidt T; Schmidt FN; von Kroge S; Busse B; Amling M; Barvencik F Bone; 2019 Oct; 127():67-74. PubMed ID: 31152801 [TBL] [Abstract][Full Text] [Related]
8. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia. Scott LJ Drugs; 2016 Feb; 76(2):255-62. PubMed ID: 26744272 [TBL] [Abstract][Full Text] [Related]
9. Asfotase alfa therapy for children with hypophosphatasia. Whyte MP; Madson KL; Phillips D; Reeves AL; McAlister WH; Yakimoski A; Mack KE; Hamilton K; Kagan K; Fujita KP; Thompson DD; Moseley S; Odrljin T; Rockman-Greenberg C JCI Insight; 2016 Jun; 1(9):e85971. PubMed ID: 27699270 [No Abstract] [Full Text] [Related]
10. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia. Hofmann C; Seefried L; Jakob F Drugs Today (Barc); 2016 May; 52(5):271-85. PubMed ID: 27376160 [TBL] [Abstract][Full Text] [Related]
11. Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase. Gasque KC; Foster BL; Kuss P; Yadav MC; Liu J; Kiffer-Moreira T; van Elsas A; Hatch N; Somerman MJ; Millán JL Bone; 2015 Mar; 72():137-47. PubMed ID: 25433339 [TBL] [Abstract][Full Text] [Related]
12. Hypophosphatasia: presentation and response to asfotase alfa. Alsarraf F; Ali DS; Almonaei K; Al-Alwani H; Khan AA; Brandi ML Osteoporos Int; 2024 Apr; 35(4):717-725. PubMed ID: 37993691 [TBL] [Abstract][Full Text] [Related]
13. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa. Kishnani PS; Del Angel G; Zhou S; Rush ET Mol Genet Metab; 2021 May; 133(1):113-121. PubMed ID: 33814268 [TBL] [Abstract][Full Text] [Related]
14. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia. Whyte MP; McAlister WH; Mumm S; Bierhals AJ Bone; 2019 May; 122():231-236. PubMed ID: 30825650 [TBL] [Abstract][Full Text] [Related]
15. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy. Bowden SA; Foster BL Drug Des Devel Ther; 2018; 12():3147-3161. PubMed ID: 30288020 [TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement therapy for hypophosphatasia-The current paradigm. Schindeler A; Ludwig K; Munns CF Clin Endocrinol (Oxf); 2024 Dec; 101(6):593-601. PubMed ID: 39004952 [TBL] [Abstract][Full Text] [Related]